10th Australasian Viral Hepatitis Conference 2016

Thank you for your interest.

The program is expected to begin at 1.30pm Thursday 29 September and conclude at 3.00pm on Saturday 1 October. Please refer to the Agenda tab for general conference proceedings. There are a number of Workshops taking place prior to the main conference, make sure you view the Associated Events page for more information.

Keep up to date with the Viral Hepatitis 2016 Conference by signing up to receive our regular Conference Newsletters.

The conference is expected to include presentations on:

  • The new HCV guidelines
  • Models of care
  • Targets including the Australian national strategies, Regional action plan and Global elimination goals
  • Eradication of hepatitis C without a vaccine
  • Eliminating hepatitis B
  • Access and cost of hepatitis C drugs
  • Burden of disease
  • Difficult scenarios for HCV and HBV treatment and management
  • Fibrosis assessment
  • What’s new in other hepatitides including coverage of Hepatitis E
  • Community empowerment including in CALD communities
  • Legal and stigma issues

Key Reasons To Attend

 Community & Social Research
1. Never before has there been a more important conference to attend in Viral Hepatitis. We are at a unique moment in history to reduce the burden of HCV in Australia and New Zealand.

2. Delegates will be informed of the latest developments in treatments and models of care

3. Delegates will come away with a better understanding of DAA treatment access and linkage to care

4. Be informed of the latest developments in HCV screening and diagnosis

5. Learn how the new treatments are being experienced by the community, by service providers and how the government is working to achieve success for all

6. Learn from real life case histories with difficult scenarios in hepatitis C and B management presented to a panel of experts

1. Join with colleagues in this watershed year and explore how valuable insights from international and local hepatitis B and hepatitis C experts can be applied to the Australian and New Zealand context.

2. Following the successful community-led advocacy for universal access to the new hepatitis C medicines in Australia the elimination of hepatitis C as a public health concern is now a realistic goal! This is an opportunity to gain an understanding of the challenges ahead and the essence of best practice treatment programs and the meaningful community engagement.

3. Learn about models of care that engage CALD and Indigenous communities for hepatitis B diagnoses, management and treatment. Hear from experts in the field around viral hepatitis community and social research taking place in PWID peer based organisations; correctional centres; Indigenous health; CALD organisations and hear from community advocates and leaders from affected communities.

4. The conference is an opportunity to collaborate with colleagues to learn how we can improve our responses and how we engage with our at risk communities to reduce the burden of hepatitis B and hepatitis C across Australasia.

 Epidemiology, Public Health & Prevention  Basic Science
1. This conference coincides with a revolutionary time for HCV in Australia, with access to new drugs vastly improving cure rates and the prospect of elimination.

2. This is the only specialist viral hepatitis conference in the region

4. See mid-term progress report against the 2014-2017 National Hepatitis B and C Strategies.

5. Great progress is being made in international policy for viral hepatitis, with the World Health Organization recently adopting the first ever global viral hepatitis strategy. Learn what this means for Australasia and the leadership role Australasia can play.

This is the most important year in Australasian Viral Hepatitis with the future prospect of Hepatitis C elimination. It represents exciting times for patients, carers and professionals alike. Delegates will:

1. Gain a greater understanding of the translational impact of basic science research on public health

2. See how all disciplines can work together to reduce the burden of HCV across Australasia

3. Be informed of the latest developments in simplified HCV screening and diagnosis

4. Learn about advances in the immunological response to hepatitis virus and their transmission

5. Better understand complementary role of vaccination and treatment in achieving elimination

6. Have a greater knowledge of the latest developments in treatments, access and linkage to care

7. Learn how the new treatments are being experienced by the community, by service providers and how the government is working to achieve success for all.